International Biotechnology (LON:IBT - Get Free Report) insider Katherine Cornish-Bowden purchased 2,000 shares of International Biotechnology stock in a transaction dated Tuesday, May 13th. The shares were purchased at an average cost of GBX 585 ($7.79) per share, for a total transaction of £11,700 ($15,570.93).
International Biotechnology Stock Performance
IBT opened at GBX 571.98 ($7.61) on Wednesday. The stock has a market capitalization of £205.46 million, a PE ratio of 5.46 and a beta of 0.21. International Biotechnology has a one year low of GBX 480 ($6.39) and a one year high of GBX 736 ($9.80). The business's 50 day moving average price is GBX 592.27 and its 200 day moving average price is GBX 661.85.
International Biotechnology (LON:IBT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported GBX (5.60) (($0.07)) EPS for the quarter. International Biotechnology had a net margin of 90.66% and a return on equity of 13.67%. As a group, equities research analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.
International Biotechnology Company Profile
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
